Pharmacogenomics and Neuroimaging for Predicting Treatment Response and Relapse in Co-Occurring Mental Illness and Substance Use Disorders: A Systematic Evidence Review
Background: Co-occurring mental illness and substance use disorders (SUDs) are associated with high clinical complexity, heterogeneous treatment response and recurrent relapse. Pharmacogenomic and neuroimaging biomarkers may complement conventional clinical predictors, but the extent to which evidence directly supports...